Voyage Biomedical is a company developing medical devices to prevent brain damage due to cardiac arrest. Voyage Biomedical endeavors to end brain damage due to cerebral ischemia using their Voyage Brain Cooling System. According to the medical literature, inducing hypothermia during and after cardiac arrest protects brain function. The company’s Boreas Central Line is designed for placement in the internal jugular vein during intensive care unit (ICU) stays for routine delivery of therapeutics. The line permits chilled saline to be directed to the brain in the even of a cardiac arrest which would cool and protect the brain. This can provide cerebral protection before brain death begins.